KUZAMPLI Trademark

Trademark Overview

On Friday, September 24, 2021, a trademark application was filed for KUZAMPLI with the United States Patent and Trademark Office. The USPTO has given the KUZAMPLI trademark a serial number of 97043465. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 30, 2026. This trademark is owned by Johnson & Johnson. The KUZAMPLI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
kuzampli

General Information

Serial Number97043465
Word MarkKUZAMPLI
Filing DateFriday, September 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 30, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
US
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
US

Trademark Events

Event DateEvent Description
Tuesday, September 28, 2021NEW APPLICATION ENTERED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 5, 2022ASSIGNED TO EXAMINER
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022NON-FINAL ACTION E-MAILED
Monday, June 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 22, 2022SUSPENSION LETTER WRITTEN
Tuesday, November 22, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, November 22, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 22, 2024SOU EXTENSION 1 FILED
Monday, January 22, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024SOU EXTENSION 2 FILED
Tuesday, August 6, 2024SOU EXTENSION 2 GRANTED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2025SOU EXTENSION 3 FILED
Tuesday, February 11, 2025SOU EXTENSION 3 GRANTED
Wednesday, February 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 25, 2025SOU TEAS EXTENSION RECEIVED
Friday, July 25, 2025SOU EXTENSION 4 FILED
Friday, July 25, 2025SOU EXTENSION 4 GRANTED
Saturday, July 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 30, 2026ABANDONMENT - NO USE STATEMENT FILED
Monday, March 30, 2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

kuzampli diseases system anti preparations pharmaceutical respiratory oncologic ophthalmic metabolic infectious